Conduit Graham Number from 2010 to 2026

CDTTW Stock   0.01  0.0008  10.67%   
Conduit Pharmaceuticals Graham Number yearly trend continues to be fairly stable with very little volatility. Graham Number will likely drop to 52.51 in 2026. During the period from 2010 to 2026, Conduit Pharmaceuticals Graham Number regression line of quarterly data had mean square error of  9.11 and geometric mean of  64.38. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
59.07
Current Value
52.51
Quarterly Volatility
3.46933353
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Conduit Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Conduit Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 567.2 K, Selling General Administrative of 14.5 M or Total Revenue of 2.9 B, as well as many indicators such as Price To Sales Ratio of 0.015, Dividend Yield of 0.13 or PTB Ratio of 0.0421. Conduit financial statements analysis is a perfect complement when working with Conduit Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Conduit Stock
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Conduit Stock Analysis

When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.